kleine Zock mit "FEMO"

chart.finance.yahoo.com/c/6m/f/femo.ob.gif" style="max-width:560px" border=0>   

• den habe ich mir einfach mal gegönnt für 0,0285 $
• eng ist immer schön ;-)

• 
  unter 0,10 US$ gebe ich keine einzige !    

   chart.finance.yahoo.com/c/1y/f/femo.ob.gif" style="max-width:560px" border=0>

  

Robert Richards, Co-Creator of Breakthrough Technologies, Joins BIOPRO Technology's Scientific Advisory Board
Wednesday April 6, 6:00 am ET

CARLSBAD, Calif., April 6 /PRNewswire-FirstCall/ -- BIOPRO Technology, a Division of FemOne, Inc. (OTC Bulletin Board: FEMO - News), a publicly held Nevada Corporation, announced today that Robert Richards joined the Company's Scientific Advisory Board. Mr. Richards is the co-founder of Clarus Products International, the California-based company that manufactures the BIOPRO QLink, one of BIOPRO's key products. Mr. Richards is considered a pioneer in the field of bioenergetics and has co-created a number of internationally acclaimed products in the field of bioenergetics and subtle energies, including the QLink.

FemOne's CEO Ray W. Grimm is excited about Robert Richards joining the Company's Scientific Advisory Board: "Robert is well respected in the bioenergetics and wellness industry and brings tremendous research contacts to us. Not only is he going to be instrumental in further substantiating our technologies, but he'll also be involved in future product development. We are very glad to have a man of his caliber on board."

Robert Richards adds: "I believe in BIOPRO's vision of becoming a major international force in the rapidly growing field of bioenergetics. I believe that with my background in this field coupled with the team of researchers I have aligned myself with over the years, I will be able to contribute to BIOPRO's future success on more than one level. I am excited about where BIOPRO is going."

Throughout his impressive career, Robert Richards has also been a featured speaker for the Young Presidents Organization in Asia, the Conference on World Affairs, and the Esalen Institute's Center for Theory and Research.

About FemOne, Inc.

FemOne, Inc. (OTC Bulletin Board: FEMO - News) is based in Carlsbad, California as a direct-selling company with distribution in the United States and Canada. More information about FemOne and its products can be found on the company's web site at www.femone.com, or by e-mail at FEMOIR@femone.com or by calling FemOne Inc. at (760) 448-2498.

Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward-looking statement.

These forward looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievement expressed or implied by such forward looking statements. In some cases, you can identify forward looking statements by terminology such as "may," "will," "should," "could," "intend," "expects," "plan," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of such terms or other comparable terminology. Although we believe that the expectations reflected in the forward looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements.

For further information please contact: Cindi Moore of FemOne, Inc., +1-760-448-2498, FEMOIR@femone.com

---

Source: FemOne, Inc.

was macht die Nase ?   Grüße auch an Zwerg ! irgendwie ist wieder alles wie immer.

FemOne Announces 2004 Earnings Results, Increased Gross Profits of 99%
Monday April 4, 8:00 pm ET

CARLSBAD, Calif., April 4 /PRNewswire-FirstCall/ -- FemOne, Inc., (OTC Bulletin Board: FEMO - News), (the "Company"), reported 2004 year end consolidated net sales of $1,917,542, an increase of 89% from the prior year. Sales from its BIOPRO Technology division, launched in early 2004, represented 70% total consolidated sales for 2004.

ADVERTISEMENT

The gross profits in 2004 increased to $1,350,653, an increase of 99% over gross profits of $680,326 in 2003.

Consolidated net loss attributable to common stockholders for the year ended December 31, 2004 was $3,138,728, or $0.11 per share, compared to net loss of $1,403,340, or $0.08 per share a year ago. The increase in net loss in 2004 was directly attributable to an increase in expenses associated with the Company's operations and efforts to continue its business growth.

Operating expenses for the year ended 2004 were $3,529,602 compared to $2,000,590 in 2003. The increase in operating expenses is due to increased commission expense on increased sales; as well as increased expenses attributable to being a publicly-reporting company.

Included in the Company's consolidated results for 2004 are revenues and expenses from its two controlled subsidiaries, BIOPRO Australasia Pty, Ltd, operating the Company's direct sales division in Australia and New Zealand, and SRA Marketing, Inc., its subsidiary for the Direct Response Shopping network. Each of these subsidiaries began their operations in the fourth quarter of 2004, and their revenues represented approximately 14% and 11%, respectively, of 2004 revenues.

Commenting on the 2004 results, Ray W. Grimm, Jr., FemOne's chief executive officer states: "We are very pleased to report to our shareholders the 99% increase in Gross Profits and the success of our BIOPRO Technology division with 70% of our sales coming from that division. We are also pleased in our growth as an international company by expanding our operations to Australia and New Zealand. Our efforts with SRA Marketing are equally exciting, since we get to explore tremendous opportunities in marketing our personal care product lines through the powerful direct response TV shopping channel."

The information contained in this press release should be read in connection with the Company's Annual Report on Form 10-KSB for the year ended December 31, 2004, containing the Report from the Company's Independent Registered Public Accounting Firm that includes a qualification as to the Company's ability to continue as a going concern, as well as other information necessary for an understanding of the Company

so macht die Börse Spaß !

0,06 oder 110% Gewinn !


also hab ich mal meinen EK rausgenommen um den neu zu positionieren / und die Gewinne machen hoffentlich weiter Gewinne ;-)


Nein: reine Phantasie und Hoffnung die ich hier verbreite - also bleibt bei den Fakten !!!

  chart.finance.yahoo.com/c/2y/f/femo.ob.gif" style="max-width:560px" border=0>    chart.finance.yahoo.com/c/6m/f/femo.ob.gif" style="max-width:560px" border=0>